Ernexa Therapeutics Inc. (ERNA) Change in Receivables (2010 - 2021)

Ernexa Therapeutics' (ERNA) quarterly Change in Receivables came in at $663680.0 in Q4 2021, up 14281.2% on a QoQ basis from -$4680.0 in Q1 2021.

Ernexa Therapeutics Inc. (ERNA) Change in Receivables (2010 - 2021) Analysis & Trends

Ernexa Therapeutics (ERNA) has 11 years of Change in Receivables data on file, last reported at $663680.0 in Q4 2021.

Quarterly Change in Receivables changed N/A year-over-year to $663680.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $659000.0 (changed N/A YoY) and the FY2021 annual result came in at $659000.0, changed N/A from the prior year.
Change in Receivables rose to $663680.0 in Q4 2021, from -$4680.0 in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $863000.0 in Q1 2017 to a low of -$990000.0 in Q2 2017.
A 4-year average of $90857.1 and a median of $53660.0 in 2017 frame the typical range for Change in Receivables.
The widest YoY moves for Change in Receivables: up 784.92% in 2017, down 673.44% in 2017.
Tracing ERNA's Change in Receivables over 4 years: stood at $112000.0 in 2017, then tumbled by 198.21% to -$110000.0 in 2018, then surged by 527.27% to $470000.0 in 2019, then jumped by 41.21% to $663680.0 in 2021.
The last three Change in Receivables figures came in at $663680.0 (Q4 2021), -$4680.0 (Q1 2021), and $470000.0 (Q4 2019), per Business Quant data.

Download Data